Cargando…
低剂量化疗联合酪氨酸激酶抑制剂诱导治疗Ph染色体阳性急性淋巴细胞白血病的疗效和安全性
OBJECTIVE: The study aims to explore the efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitor (TKI) as an induction therapy for Philadelphia-chromosomal-positive acute lymphoblastic leukemia (Ph(+) ALL). METHODS: The data of the consecutive newly diagnosed patients wi...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395566/ https://www.ncbi.nlm.nih.gov/pubmed/36709131 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.07.004 |